Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: The Whitehall II study

European Journal of Endocrinology

Volumn 162, Issue 5, 2010, Pages 913-917

  Carstensen, Maren ^a   Herder, Christian ^a   Brunner, Eric J ^b   Strassburger, Klaus ^a   Tabak, Adam G ^b,c   Roden, Michael ^a   Rwitte, Daniel ^b,d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6;

ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOCIAL STATUS; WAIST CIRCUMFERENCE;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; MALE; MIDDLE AGED; WAIST CIRCUMFERENCE;

EID: 77951655973     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-1066     Document Type: Article

References (19)

1. Kolb H & Mandrup-Poulsen T. An immune origin of type 2 diabetes? Diabetologia 2005 48 1038-1050.
2. Herder C, Brunner EJ, Rathmann W, Strassburger K, Tabak AG, Schloot NC & Witte DR. Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes. Diabetes Care 2009 32 421-423.
3. Li S, Shin HJ, Ding EL & von Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. Journal of the American Medical Association 2009 302 179-188.
4. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairle WD, Por SB, Robbins JM & Breit SN. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. PNAS 1997 94 11514-11519.
5. Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR,Wu L, Pankhurst G, Jiang L, Junankar S, Hunter M, Fairlie WD, Lee NJ, Enriquez RF, Baldock PA, Corey E, Apple FS, Murakami MM, Lin EJ, Wang C, During MJ, Sainsbury A, Herzog H & Breit SN. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nature Medicine 2007 13 1333-1340.
6. Ding Q, Mracek T, Gonzalez-Muniesa P, Kos K, Wilding J, Trayhurn P & Bing C. Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology 2009 150 1688-1696.
7. Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-Cahn R, Gueripel X, Ellingsgaard H, Schneider MKJ, Biollaz G, Fontana A, Reinecke M, Homo-Delarche F & Donath MY. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 2007 56 2356-2370.
8. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL & Ferrrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003 112 1796-1808.
9. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA & Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003 112 1821-1830.
10. Curat CA, Miranville A, Sengenes C, Diehl M, Tonus C, Busse R & Bouloumie A. From blood monocytes to adipose tissue - resident macrophages induction of diapedesis by human mature adipocytes. Diabetes 2004 53 1285-1292.
11. + monocytes occurs in diabetes. Diabetes 2005 54 2779-2786.
12. Dostalova I, Roubicek T, Bartlova M, Mraz M, Lacinova Z, Haluzikova D, Kavalkova P, Matoulek M, Kasalicky M & Haluzik M. Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low caloric diet. European Journal of Epidemiology 2009 161 397-404.
13. Marmot M & Brunner E. Cohort profile: the Whitehall II study. International Journal of Epidemiology 2005 34 251-256.
14. Herder C, Zierer A, Koenig W, Roden M, Meising C & Thorand B. Transforming growth factor-beta1 and incident type 2 diabetes: results from the MONICA/KORA case-cohort study, 1984-2002. Diabetes Care 2009 32 1921-1923.
15. Serhan CN & Savill J. Resolution of inflammation: the beginning programs the end. Nature Immunology 2005 6 1191-1197.
16. Kolb H & Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 2010 53 10-20.
17. Brown DA, Breit SN, Buring J, Fairlie WD, Bauskin AR, Lin T & Ridker PM. Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet 2002 359 2159-2163.
18. Wollert KC, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Allhoff T, Peter T, Siegbahn A, Venge P, Drexler H & Wallentin L. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome. Circulation 2007 116 1540-1548.
19. Kempf T, Sinning J-M, Quint A, Bickel C, Sinning C, Wild PS, Schnabel R, Lubos E, Rupprecht HJ, Münzel T, Drexler H, Blankenberg S & Wollert K. Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study. Circulation. Cardiovascular Genetics 2009 2 286-292.